Co-Authors
This is a "connection" page, showing publications co-authored by Fengcai Zhu and Ying Chi.
Connection Strength
0.396
-
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. J Infect Dis. 2020 08 04; 222(5):746-754.
Score: 0.224
-
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. Signal Transduct Target Ther. 2021 04 24; 6(1):165.
Score: 0.059
-
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV. J Virol. 2021 01 28; 95(4).
Score: 0.058
-
Association of viral load with serum biomakers among COVID-19 cases. Virology. 2020 07; 546:122-126.
Score: 0.055